BioReplicon is an early-stage biotechnology company founded by graduates of the MSTC (Master of Science in Technology Commercialization) program at the University of Texas at Austin.  With combined expertise in science, marketing, business management, intellectual property, and product development, we are dedicated to the development and commercialization of innovative medical diagnostics and information systems to address unmet medical needs.

Our first product, SeptiCatchTM, is a nucleic acid-based in vitro diagnostic test designed to address the unmet need of early sepsis detection.